News
- Researchers discover new blood group system - MAL 16 September 2024 The discovery of a new blood group, MAL, has solved a 50- year-old mystery. Researchers from NHS Blood and Transplant (Bristol), NHSBT’s International Blood Group Reference Laboratory (IBGRL) and the University of Bristol identified the genetic background of the previously known but mysterious AnWj blood group antigen. The findings allow identification and treatment of rare patients lacking this blood group.
- Pioneering report exposes worsening health threats of climate change in UK 5 September 2024 A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the effects of climate change deepen.
- Study of 18 million people finds increased mental illnesses incidence following severe COVID-19, especially in unvaccinated people 21 August 2024 A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry today [21 August], investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.
- Incidence of heart attacks and strokes was lower after COVID-19 vaccination, finds study of 46 million adults 31 July 2024 A new study involving nearly the whole adult population of England has found that the incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination. The research, involving University of Bristol researchers, is published in Nature Communications today [31 July].
- Bristol spinout lands patent for pioneering point-of-care technology 26 July 2024 A University of Bristol spinout company developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs) has taken a significant step forward after having a key patent granted.
- Bristol researcher awarded share of UKRI’s £104 million flagship fellowships grant 23 July 2024 A University of Bristol academic has been awarded a share of the UKRI’s £104 million flagship fellowships grant.
- New study identifies two proteins that may contribute to stroke recurrence 22 July 2024 People who experience an arterial ischemic stroke (AIS) or transient ischemic stroke (TIA) are at an increased risk of suffering a second stroke or other major adverse cardiovascular event (MACE), making it critically important to identify risk factors and treatments to prevent these subsequent occurrences. The new study, led by Boston University School of Public Health (BUSPH) and University of Bristol researchers, has identified new genetic and molecular risk factors that may reveal new pathways for treating patients after they experience their first stroke.
- New films set to boost effective adoption of Health Impact Assessments 18 July 2024 Expert voices from planning, health, government and consultants have shared their insights of using Health Impact Assessments as a force for good to create healthier new communities.
- Time to act on kidney health inequalities, report reveals 16 July 2024 Kidney health inequalities due to age, sex, education, location or lack of wealth persist, despite widespread awareness of the barriers some people face, a new report by Kidney Research UK has revealed.
- Over-the-counter nasal sprays could keep coughs, colds and flu at bay and reduce antibiotic use 12 July 2024 Widely available over-the counter nasal sprays could keep upper respiratory tract infections - like colds, chest infections, flu, sore throat, and sinus infections - at bay, and prevent full-blown symptoms from developing, one of the largest trials to date to test their effectiveness finds. The research, which analysed data from nearly 14,000 adults, found overall they reduced the days of illness by around 20 per cent, and also reduced the number of days with severe symptoms, time off work or normal activities, and antibiotic use.
Infection and immunity press releases
Press releases relating to infection and immunity on the University's central news pages.
Infection and immunity newsletters
View previous Infection and Immunity newsletters with staff and research news 2015-2023.
Subscribe to the Infection and Immunity mailing list
If you would like to be added to the Infection and Immunity mailing list, email the Network administrator.